A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia



Status:Completed
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:8/3/2016
Start Date:March 2005
End Date:January 2007

Use our guide to learn which trials are right for you!

A Randomized, Double-blind Study of the Effect of Beta-lactam on Treatment Response in Patients Hospitalized With Bacterial Pneumonia

This study will assess the efficacy and safety of intravenous beta-lactam, in comparison
with ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by
Legionella. The anticipated time on study treatment is 3-12 months and the target sample
size is 100-500 individuals.


Inclusion Criteria:

- male or female patients at least 18 years of age;

- hospitalization with community-acquired pneumonia or development of pneumonia within
48 hours of being hospitalized for another reason;

- fever;

- new or increased productive cough;

- chest pain, shortness of breath, or rapid breathing.

Exclusion Criteria:

- requiring intubation or ventilation;

- nursing home or extended care within 60 days before study;

- concomitant bacterial infection requiring antibiotics;

- long-term immunosuppressive therapy.
We found this trial at
7
sites
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
?
mi
from
Butte, MT
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Holmdel, NJ
Click here to add this to my saved trials
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials